Have a feature idea you'd love to see implemented?
Let us know!
VIGL Vigil Neuroscience Inc
Price (delayed)
$3
Market cap
$122.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.06
Enterprise value
$89.99M
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is
Highlights
The debt has decreased by 6% YoY
Vigil Neuroscience's EPS has increased by 2.8% from the previous quarter
Vigil Neuroscience's equity has decreased by 35% YoY but it has increased by 3.8% from the previous quarter
The quick ratio has dropped by 72% year-on-year and by 55% since the previous quarter
The company's net income fell by 4.7% YoY
Key stats
What are the main financial stats of VIGL
Market
Valuations
Earnings
Shares outstanding
40.88M
Market cap
$122.64M
Enterprise value
$89.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.34
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$82.6M
EBITDA
-$80.76M
Free cash flow
-$48.61M
Per share
Balance sheet
Liquidity
EPS
-$2.06
Free cash flow per share
-$1.2
Book value per share
$2.23
Revenue per share
$0
TBVPS
$3.24
Total assets
$131.27M
Total liabilities
$42.72M
Debt
$13.18M
Equity
$88.55M
Working capital
$83.14M
Debt to equity
0.15
Current ratio
3.72
Quick ratio
3.67
Net debt/EBITDA
0.4
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-65.3%
Return on equity
-83.9%
Return on invested capital
-107.1%
Return on capital employed
-82%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VIGL stock price
How has the Vigil Neuroscience stock price performed over time
Intraday
-1.64%
1 week
-5.66%
1 month
-21.88%
1 year
-8.26%
YTD
-11.24%
QTD
-11.76%
Financial performance
How have Vigil Neuroscience's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$88.43M
Net income
-$82.6M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 5% YoY
The company's net income fell by 4.7% YoY
Growth
What is Vigil Neuroscience's growth rate over time
Valuation
What is Vigil Neuroscience stock price valuation
P/E
N/A
P/B
1.34
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Vigil Neuroscience's EPS has increased by 2.8% from the previous quarter
Vigil Neuroscience's equity has decreased by 35% YoY but it has increased by 3.8% from the previous quarter
The stock's price to book (P/B) is 4.3% less than its last 4 quarters average of 1.4
Efficiency
How efficient is Vigil Neuroscience business performance
The return on equity has dropped by 73% year-on-year and by 10% since the previous quarter
The return on assets has dropped by 50% year-on-year and by 3.8% since the previous quarter
The ROIC has contracted by 13% YoY and by 10% from the previous quarter
Dividends
What is VIGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VIGL.
Financial health
How did Vigil Neuroscience financials performed over time
VIGL's total liabilities has surged by 84% since the previous quarter and by 83% year-on-year
The company's current ratio has shrunk by 73% YoY and by 56% QoQ
The debt is 85% less than the equity
Vigil Neuroscience's debt to equity has soared by 50% YoY but it has decreased by 6% from the previous quarter
Vigil Neuroscience's equity has decreased by 35% YoY but it has increased by 3.8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.